EQUITIES-CONFERENCE Related Post navigation Previous Previous post: How Lexaria Bioscience’s Innovative Patent Portfolio Propels the CBD Market to the Next LevelNext Next post: Invictus is Flush With $20 Million in New Funding, Making Cannabis Deliveries and Pursuing EU-GMP Certification for Sales in Europe